HIF-2⍺ is a key transcriptional regulator that helps drive the growth of many solid tumors. HIF-2⍺ is regulated through degradation and is normally only stably expressed and accumulated in cells under hypoxic conditions. Hypoxic tumors correlate highly with upregulation of the adenosine pathway, suggesting that targeting the adenosine pathway may enhance the antitumor activity of AB521.
